Neurocrine Biosciences, Inc. · NASDAQ:NBIX

Lyons Gary A exercised options for 1,659 Neurocrine Biosciences, Inc. shares (Form 4)

Traded May 21, 2026 · Filed May 21, 2026

On May 21, 2026, Lyons Gary A (Director) exercised options for 1,659 Neurocrine Biosciences, Inc. shares, leaving 122,141 shares. Filed May 21, 2026 (Form 4).

Options exercised
1,659 shares
Holding after
122,141 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockOption exercise1,659122,141Direct

Source

View original at SEC

Related